Targeting IL-10 Family Cytokines for the Treatment of Human Diseases

Cold Spring Harb Perspect Biol. 2019 Feb 1;11(2):a028548. doi: 10.1101/cshperspect.a028548.

Abstract

Members of the interleukin (IL)-10 family of cytokines play important roles in regulating immune responses during host defense but also in autoimmune disorders, inflammatory diseases, and cancer. Although IL-10 itself primarily acts on leukocytes and has potent immunosuppressive functions, other family members preferentially target nonimmune compartments, such as tissue epithelial cells, where they elicit innate defense mechanisms to control viral, bacterial, and fungal infections, protect tissue integrity, and promote tissue repair and regeneration. As cytokines are prime drug targets, IL-10 family cytokines provide great opportunities for the treatment of autoimmune diseases, tissue damage, and cancer. Yet no therapy in this space has been approved to date. Here, we summarize the diverse biology of the IL-10 family as it relates to human disease and review past and current strategies and challenges to target IL-10 family cytokines for clinical use.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / immunology
  • Cytokines / genetics
  • Cytokines / metabolism*
  • Cytokines / therapeutic use
  • Gene Expression Regulation / drug effects*
  • Humans
  • Inflammation / drug therapy*
  • Inflammation / immunology
  • Interleukin-10 / chemistry
  • Interleukin-10 / physiology
  • Interleukin-10 / therapeutic use
  • Neoplasms / drug therapy*
  • Neoplasms / immunology

Substances

  • Cytokines
  • Interleukin-10